John Betteridge

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

John Dormandy, B Charbonnel, D.J.A. Eckland et al. · The Lancet · 2005 · 4.1K citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)

L Rydén, Eberhard Standl, M. Bartnik et al. · European Heart Journal · 2006 · 1.7K citations · Full text

Medicine, Cardiology, Endocrinology +17

Mental Stress Induces Transient Endothelial Dysfunction in Humans

Lorenzo Ghiadoni, Ann E. Donald, Mark Cropley et al. · Circulation · 2000 · 660 citations

Veterinary Medicine, Cardiology, Physiology +16

IS ERECTILE DYSFUNCTION A MARKER FOR CARDIOVASCULAR DISEASE?

Mike Kirby, Graham Jackson, John Betteridge et al. · International Journal of Clinical Practice · 2001 · 164 citations

Medicine, Cardiology, Pharmacotherapy +13

Association Between Acute-Phase Reactants and Advanced Glycation End Products in Type 2 Diabetes

K. C. B. Tan, Wing-Sun Chow, Sidney Tam et al. · Diabetes Care · 2004 · 115 citations · Full text

Veterinary Medicine, Endocrinology, Immunology +16